Organic Isothiocyanates: Dietary Modulators of Doxorubicin Resistance in Breast Cancer
Abstract
Drug resistance is the main cause for therapeutic failure and death in breast cancer. Our goal is to evaluate dietary organic isothiocyanates (ITCs) as inhibitors of MDR. The first two specific aims of our proposal are: 1) To determine the concentration-dependent effects of benzyl ITC (BITC), phenethyl ITO (PEITC) and naphthyl ITC (NITC) on the accumulation of 3H-daunomycin (DNM) in sensitive and resistant human breast cancer cell lines; and 2) To evaluate the pharmacokinetics and toxicity of NITC, PEITC and BITC in the rat following oral and intravenous administration. NITC, PEITC and BITC significantly increased the cellular accumulation of DNM and vinblastine (VBL) in resistant human breast cancer MCF-7 cells at 20-100 micrometers concentrations, without affecting accumulation in MCF-7 sensitive cells. Cytotoxicity studies revealed that PEITC and BITC inhibited the growth of both the MCF-7 and normal mammary MCF-12A cell lines. Assays to determine PEITC, BITC and NITC in biological fluids were developed, and stability studies demonstrated limited stability of NITC in biological fluids at RT, while PEITC and BITC degraded with half-lives of 36 and 40 h, respectively, at pH 7.4. Characterization of the pharmacokinetics of NITC in rats revealed a high clearance (2.29+/-0.81 L/kg/h) and large volume of distribution (16.8+/-3.6 L/kg). The ITCs may represent a new class of inhibitors of MDR in breast cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2002
- Accession Number
- ADA407743
Entities
People
- Marilyn E. Morris
Organizations
- University at Buffalo